Global death toll from COVID-19 could reach 2 million before vaccine is widely used

GENEVA / ZURICH – The global death toll from COVID-19 could double to 2 million before a successful vaccine is widely used and could be even higher without concerted action to curb the pandemic, a World Organization official said on Friday Of the health. We do it all, (2 million deaths) … not only is it imaginable, but sadly, it is very likely, “said Mike Ryan, head of the UN agency’s emergency program, in a briefing on Friday. The new coronavirus discovered in China is approaching 1 million “We are not out of danger anywhere, we are not out of danger in Africa,” Ryan said. He said young people should not be blamed for a recent increase in Infections despite growing concerns that are fueling their spread after restrictions and closures were eased around the world. “I really hope we don’t get moving – it’s all down to the youth,” Ryan said. The last thing a young person needs is an older person to pontificate and wave his finger. ”Rather, indoor gatherings of people of all ages were driving the epidemic, he said.The WHO is continuing talks with China about its possible participation in the COVAX funding scheme designed to ensure rapid and equitable global access to COVID-19 vaccines, a week after the deadline to commit passed. “We are in talks with China about the role they can play as we move forward,” said Bruce Aylward, WHO senior adviser and head of the ACT-Accelerator program to support COVID-19 vaccines, treatments and diagnostics. He confirmed that Taiwan has adhered to the plan, even though it is not a member of the WHO, bringing the total to 159 participants. Some 34 are still deciding. The talks with China also include a discussion about the world’s second-largest economy that could supply vaccines to the scheme, he said. WHO Deputy Director-General Mariangela Simao said the document will be available for public comment until October 8, said early Friday, a Chinese health official said WHO had provided its support for the country to begin administering experimental coronavirus vaccines to people even when clinical trials are still ongoing.